| Schedule of Remuneration Attributed to Key Management Personnel |
Remuneration
attributed to key management personnel are summarized as follows:
| | |
Three
months
ended
June 30,
2026 | | |
Three
months
ended
June 30,
2025 | | |
Six
months
ended
June 30,
2026 | | |
Six
months
ended
June 30,
2025 | |
| Consulting fees | |
$ | 175,200 | | |
$ | 147,700 | | |
$ | 352,800 | | |
$ | 295,400 | |
| Management fees | |
| 99,091 | | |
| - | | |
| 182,199 | | |
| - | |
| Director fees | |
| 41,640 | | |
| 83,290 | | |
| 83,280 | | |
| 83,290 | |
| Bonus | |
| 1,050,000 | | |
| - | | |
| 2,082,415 | | |
| 300,000 | |
| Salaries | |
| - | | |
| - | | |
| - | | |
| 26,228 | |
| Share-based compensation | |
| 174,545 | | |
| 15,842 | | |
| 182,761 | | |
| 36,616 | |
| | |
$ | 1,540,476 | | |
$ | 246,832 | | |
$ | 2,883,455 | | |
$ | 741,533 | |
|
| Schedule of Fair Value, as Calculated on the Grant Date, to Each Related Party |
Details
of the fair value, as calculated on the grant date, to each related party in the current and prior periods, and the related expense recorded
for the six months ended June 30, 2026, and 2025 are as follows:
| | |
Six Months
Ended
June 30,
2026 | | |
Six Months
Ended
June 30,
2025 | | |
Grant date
fair value | |
| Braeden Lichti, Non-executive Chairman | |
$ | 67,307 | | |
$ | 11 | | |
$ | 659,029 | |
| Graydon Bensler, CEO, CFO and Director | |
| 67,307 | | |
| 11 | | |
| 659,029 | |
| Jordan Plews, Former Director and former CEO of Skincare and BioSciences2 | |
| - | | |
| 11 | | |
| 50,995 | |
| Jeffrey Parry, Director | |
| 13,145 | | |
| 6,428 | | |
| 209,008 | |
| Julie Daley, Director | |
| 19,424 | | |
| 19,592 | | |
| 311,584 | |
| George Kovalyov, Director | |
| 15,578 | | |
| 10,562 | | |
| 121,243 | |
| | |
$ | 182,761 | | |
$ | 36,616 | | |
$ | 2,010,888 | |
|